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Background:  Patients with diabetes have an increased risk for allograft rejection, possibly related
to peri-operative hyperglycaemia. Hyperglycaemia is also common following transplantation in pa-
tients without diabetes. We hypothesise that exposure of allograft tissue to hyperglycaemia could
influence the risk for rejection in any patient with high sugars. To investigate the relationship of
peri-operative glucose control to acute rejection in renal transplant patients without diabetes, all
patients receiving their first cadaveric graft in a single center were surveyed and patients without
diabetes receiving cyclosporin-based immunosuppression were reviewed (n = 230). Records of the
plasma blood glucose concentration following surgery and transplant variables pertaining to allo-
graft rejection were obtained. All variables suggestive of association were entered into multivariate
logistic regression analysis, their significance analysed and modeled.
Results:  Hyperglycaemia (>8.0 mmol/L) occurs in over 73% of non-diabetic patients following sur-
gery. Glycaemic control immediately following renal transplantation independently predicted acute
rejection (Odds ratio=1.08). 42% of patients with a glucose < 8.0 mmol/L following surgery devel-
oped rejection compared to 71% of patients who had a serum glucose above this level. Hypergly-
caemia was not associated with any delay of graft function.
Conclusion:  Hyperglycaemia is associated with an increased risk for allograft rejection. This is
consistent with similar findings in patients with diabetes. We hypothesise a causal link concordant
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Model predictors for allograft rejection
Variable Risk ratio Standard Error P>|z| 95% confidence limits
Age (years) 0.993 0.002 0.009 .9894094 .9985157
Immediate graft function 0.782 0.101 0.060 .6065589 1.009974
Azathioprine/MMF 1.159 0.118 0.147 .9493317 1.416481
PRA> 50% + Prednisolone 0.595 0.104 0.003 .4221672 .8384729
Number of HLA-matches 0.944 0.023 0.016 .9004449 .9894315
Glucose (mmol/L) 1.015 0.004 0.000 1.008164 1.022061







Fractional polynomial showing the probability of rejection in 
sensitised and un-sensitised CD1 patients versus the immedi-
ate post operative glucose level.
Figure 2
Fractional polynomial showing the probability of rejection in 
sensitised and un-sensitised CD1 patients versus the immedi-
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